Haleon

Yahoo Finance • 3 months ago

Pfizer to Pare Haleon Stake With 540 Million Share Offering

(Bloomberg) -- Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health giant. Most Read from Bloomberg A 7,000-Year-Old City Emerges as a Haven from Dubai’s Sky-High Ren... Full story

Yahoo Finance • 3 months ago

Estimating The Fair Value Of Haleon plc (LON:HLN)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Haleon fair value estimate is UK£3.38 Haleon's UK£3.87 share price indicates it is trading at similar levels as its fair value estimate Analyst price target for HLN is UK£3.84, whic... Full story

Yahoo Finance • 7 months ago

Trending tickers: Tesla, Reddit, Walmart and GSK

Tesla must climb ‘Mount Everest’ to win shareholder vote, chair warns. (Genaro Molina via Getty Images) Tesla (TSLA) Tesla faces a climb up “Mount Everest” as it tries to persuade shareholders to approve a relocation to Texas and sign of... Full story

Yahoo Finance • 10 months ago

Bayer AG Emerges as a New Key Player in Kahn Brothers' Portfolio with a 1.04% Stake

Insights from Kahn Brothers (Trades, Portfolio)' Latest 13F Filing for Q4 2023 Warning! GuruFocus has detected 9 Warning Signs with AGO. Kahn Brothers (Trades, Portfolio) Group, a stalwart in the value investing arena, has disclosed its... Full story

Yahoo Finance • last year

Kenvue: A High-Quality Consumer Health Company on Sale

In May, Kenvue Inc. (NYSE:KVUE) successfully concluded its separation from Johnson & Johnson (NYSE:JNJ); however, its stock has experienced a decline about 25% since the completion of this process, likely driven by Investors nervousness ab... Full story

Yahoo Finance • last year

UK falls to third place in global Health Inclusivity Index

More than three in five (63%) people in the UK experience barriers to health inclusion People in UK, Canada and France face the longest waiting times to see a GP Health inclusivity scores fall worldwide with addition of lived experience da... Full story

Yahoo Finance • last year

Health exclusion affects more than three in five people globally

Phase two of Economist Impact’s Health Inclusivity Index, supported by Haleon, measures experience of health inclusion across 42,000 people in 40 countries Health inclusivity scores fall worldwide with addition of lived experience data, ex... Full story

Yahoo Finance • last year

Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger, Novo Nordisk's Weight Loss Drugs May Pose Serious Stomach Risks, Netflix's Local Content and Pricing Woes Undermine Growth in India: Today's Top Stories

Bloomberg Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger The merger between the PGA Tour and Saudi-backed LIV Golf, initially set to be finalized by December 31, faces potential delays amid regulatory concerns in the U.... Full story

Yahoo Finance • last year

New global study discovers people in pain feel more socially excluded than ever

Latest edition of Haleon Pain Index finds half (49%) of people in pain feel stigmatised[1][2]42% regularly feel lonely due to their pain, and one third feel serious loneliness (based on UCLA loneliness scale)[3]32% of people living in pain... Full story

Yahoo Finance • 2 years ago

25 Most Prescribed Medication in the World

In this article, we will be taking a look at the 25 most prescribed medication in the world. To skip our detailed analysis, you can go directly to see the 10 most prescribed medication in the world. The advancements that the medical field... Full story

Yahoo Finance • 2 years ago

Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz

Johnson & Johnson (NYSE: JNJ) is reportedly readying an investor roadshow to pitch shares of its consumer-healthcare spinoff business, dubbed Kenvue, as early as Monday. Kenvue plans to start meeting with prospective investors with a goal... Full story

Yahoo Finance • 2 years ago

Advil Maker Haleon Said to Study Potential Deals to Bulk Up

(Bloomberg) -- Haleon Plc, the consumer health business spun out from British pharmaceutical producer GSK Plc, is in the early stages of studying large potential deals to bulk up its brand portfolio, people with knowledge of the matter sai... Full story

Yahoo Finance • 2 years ago

10 Recent Spin-off Companies That Hedge Funds Are Piling Into

In this article, we discuss 10 recent spin-off companies that hedge funds are piling into. If you want to see more stocks in this selection, check out 5 Recent Spin-off Companies That Hedge Funds Are Piling Into. A spin-off occurs when a... Full story

Yahoo Finance • 2 years ago

FTSE 100 and European stocks extend gains ahead of Powell’s Jackson Hole speech

The FTSE 100 is being pushed by mining and banking stocks. Photo: Vuk Valcic/SOPA Images/LightRocket via Getty The FTSE 100 and European stocks are off to a good start, shaking off jitters around the looming energy crisis as investors eye... Full story

Yahoo Finance • 2 years ago

3 Drug Companies Fall on Zantac Lawsuit Fears. It Shows the Power of Analysts.

Sanofi, GSK, and Haleon had big market drops for two straight days after UBS weighed in with a downgrade of Sanofi.... Full story

Yahoo Finance • 2 years ago

GSK, Sanofi and Haleon slump on worries over Zantac litigation

European-listed shares of drugmakers Haleon , GSK and Sanofi plunged on Thursday on worries over the Zantac heartburn medication litigation. The first trial is set to begin on Aug. 22. GSK shares dropped 10% in London, as Sanofi and Haleon... Full story

Yahoo Finance • 2 years ago

10 Best Medical Stocks Under $10

In this article, we will discuss the 10 best medical stocks under $10. To skip our detailed analysis of the healthcare sector, go directly to the 5 Best Medical Stocks Under $10. According to the Centers for Medicare and Medicaid Services... Full story

Yahoo Finance • 2 years ago

FTSE 100: GSK raises guidance after strong demand for shingles vaccine

Sales of the Shingrix vaccine by GSK have more than doubled to £731m. Photo: Reuters/Loriene Perera Pharmaceutical firm GSK (GSK.L) has raised its full-year guidance thanks to strong sales of its shingles vaccine Shingrix. The drugs gian... Full story